Back to XERS
MORGAN STANLEY XERS Position History
Xeris Biopharma Holdings, Inc. • Healthcare
Quarters held
30
Latest value
$56K
Q2 2026
Peak value
$20.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $466K |
| Q3 2025 | $26K |
| Q3 2025 | $610K |
| Q3 2025 | $1.5M |
| Q3 2025 | $406K |
| Q3 2025 | $19K |
| Q3 2025 | $2.5M |
| Q3 2025 | $20.7M |
| Q4 2025 | $290 |
| Q4 2025 | $650K |
| Q4 2025 | $1.2M |
| Q4 2025 | $335K |
| Q4 2025 | $18K |
| Q4 2025 | $1.5M |
| Q4 2025 | $17.6M |
| Q1 2026 | $134K |
| Q1 2026 | $486K |
| Q1 2026 | $573K |
| Q1 2026 | $349K |
| Q1 2026 | $3K |
| Q1 2026 | $401K |
| Q1 2026 | $13M |
| Q1 2026 | $800 |
| Q2 2026 | $721K |
| Q2 2026 | $775K |
| Q2 2026 | $536K |
| Q2 2026 | $4K |
| Q2 2026 | $423K |
| Q2 2026 | $16M |
| Q2 2026 | $56K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $56K | 7.0K | — | — |
| Q2 2026 | $16M | 2.02M | — | — |
| Q2 2026 | $423K | 53.4K | — | — |
| Q2 2026 | $4K | 546 | — | — |
| Q2 2026 | $536K | 67.7K | — | — |
| Q2 2026 | $775K | 97.8K | — | — |
| Q2 2026 | $721K | 91.0K | — | — |
| Q1 2026 | $800 | 138 | — | — |
| Q1 2026 | $13M | 2.24M | — | — |
| Q1 2026 | $401K | 69.1K | — | — |
| Q1 2026 | $3K | 546 | — | — |
| Q1 2026 | $349K | 60.1K | — | — |
| Q1 2026 | $573K | 98.8K | — | — |
| Q1 2026 | $486K | 83.8K | — | — |
| Q1 2026 | $134K | 23.1K | — | — |
| Q4 2025 | $17.6M | 2.24M | — | — |
| Q4 2025 | $1.5M | 188.9K | — | — |
| Q4 2025 | $18K | 2.3K | — | — |
| Q4 2025 | $335K | 42.6K | — | — |
| Q4 2025 | $1.2M | 152.5K | — | — |
| Q4 2025 | $650K | 82.8K | — | — |
| Q4 2025 | $290 | 37 | — | — |
| Q3 2025 | $20.7M | 2.54M | — | — |
| Q3 2025 | $2.5M | 305.1K | — | — |
| Q3 2025 | $19K | 2.3K | — | — |
| Q3 2025 | $406K | 49.9K | — | — |
| Q3 2025 | $1.5M | 189.4K | — | — |
| Q3 2025 | $610K | 74.9K | — | — |
| Q3 2025 | $26K | 3.1K | — | — |
| Q3 2025 | $466K | 57.3K | — | — |